Page 4482 - Week 12 - Thursday, 24 October 2019

Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video


from Category 1 to Category 3, (d) changed from Category 2 to Category 1, (e) changed from Category 3 to Category 2 and (f) changed from Category 3 to Category 1 during 2018-19.

(2) What consultation occurs with the patients GP or specialist before a patient is reclassified and is consultation mandatory or discretionary.

Mr Rattenbury: The answer to the member’s question is as follows:

(1) The information sought is not available at this time. To collect, assemble and validate the information sought solely for the purpose of answering the question would require a considerable diversion of resources.

(2) Information regarding consultation and classification is outlined in the Waiting Time and Elective Surgery Policy at Attachment A, the policy is available on the ACT Health website.

(A copy of the attachment is available at the Chamber Support Office).

ACT Health—market research
(Question No 2729)

Mrs Dunne asked the Minister for Health, upon notice, on 20 September 2019 (redirected to the Acting Minister for Health):

(1) What market research has (a) ACT Health and (b) Canberra Health Services commissioned since 1 January 2019.

(2) How much has each market research project commissioned by (a) ACT Health and (b) Canberra Health Services since 1 January cost.

(3) Who has conducted the market research projects commissioned by (a) ACT Health and (b) Canberra Health Services since 1 January 2019.

(4) What has the market research conducted by (a) ACT Health and (b) Canberra Health Services been used for.

Mr Rattenbury: The answer to the member’s question is as follows:

(1)– (4)

(a) ACT Health Directorate commissioned market research in June 2019 to supplement current data from large internet-based surveys of sexual health amongst Australian youth with a more in-depth exploration of local factors influencing sexual health behaviours in the ACT. The research undertaken by Colmar Bruntor Research Pty Ltd is to inform the development of a communication campaign to address increasing rates of sexually transmissible infections in the ACT. The total cost of the service was $47,264.80 (GST Inclusive). The market research included testing a number of creative concepts and key messages.

(b) Canberra Health Services commissioned consumer focus group testing of communication materials as part of the Maternity Options campaign. Findings from this research has been used to develop the overall look and feel of the


Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video